does glp 1 increase risk of cancer GLP-1 Side Effects and Risk: What Current Research Really Shows GLP-1 drugs cut breast cancer

The present study provides preliminary evidence in favor of the GLP-1 based therapies in providing beneficial effects against atherosclerosis as indicated by the significant reductions in atherosclerosis markers including BNP, PAI-1 and hsCRP, besides statistically non-significant reductions in several other markers including IMT, FMD, IL-6 and TNF- were also noted

Cases of monotherapy and polytherapy with GLP-1 RAs

Industry Oversight FDA regulators have so far prioritized cracking down on compounded versions of GLP-1 drugs unapproved, customized medications that are barred from mass production

3, significant superiority in primary CV outcome was observed in three CVOTs using GLP-1 RAs (liraglutide OD in LEADER [56], dulaglutide OW in REWIND [36], and semaglutide OW in SUSTAIN 6 [non-inferiority and superiority were demonstrated in SUSTAIN 6 and pre-specified sensitivity analyses, respectively] [37])